SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-145157
Filing Date
2017-04-28
Accepted
2017-04-28 07:00:57
Documents
9
Period of Report
2017-06-22
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d279122ddef14a.htm DEF 14A 344685
2 GRAPHIC g279122g74u23.jpg GRAPHIC 9097
3 GRAPHIC g279122g76n92.jpg GRAPHIC 9097
4 GRAPHIC g279122pc02.jpg GRAPHIC 45203
5 GRAPHIC g279122pc03.jpg GRAPHIC 7303
6 GRAPHIC g279122pc04.jpg GRAPHIC 14848
7 GRAPHIC g279122pc05.jpg GRAPHIC 35895
8 GRAPHIC g279122pc06.jpg GRAPHIC 7268
9 GRAPHIC g279122pc1_2.jpg GRAPHIC 41596
  Complete submission text file 0001193125-17-145157.txt   581404
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35945 | Film No.: 17791620
SIC: 2834 Pharmaceutical Preparations